EGM Statement

RNS Number:0334Q
Biotrace International PLC
23 September 2003

For Immediate Release:                                 Tuesday 23 September 2003

                           BIOTRACE INTERNATIONAL PLC

                                 EGM Statement

Biotrace International Plc, a leading manufacturer and provider of industrial
microbiology products and related services, is pleased to announce that,
following its Extraordinary General Meeting, held yesterday all resolutions
relating to the acquisition of International BioProducts Inc. ("IBP") were duly
passed. IBP is a leading US manufacturer and supplier of industrial microbiology
products based in Seattle, Washington, USA.

Accordingly an application has today been made to the UK Listing Authority and
the London Stock Exchange for a total of 1,521,539 ordinary shares of 10p each
in the Company ("Ordinary Shares") to be admitted to the Official List and to
trading on the

London Stock Exchange's main market.

Admission of the Ordinary Shares is expected to become effective on 24 September
2003.

Following the meeting Ian Johnson, Chief Executive of Biotrace said;

"This is a great opportunity to build real scale in our industry and we are
extremely pleased that the acquisition has met shareholder approval. We look
forward to updating the market as we continue to strengthen our presence in
North America."

                                    - ENDS -


For further information, please contact:

Biotrace International Plc                            Tel: [phone]
Ian Johnson, Chief Executive

Buchanan Communications                               Tel: [phone]
Tim Anderson / James Strong


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
EGMBLGDCSXDGGXD